Literature DB >> 8047348

[Natural course of coxarthrosis in dysplastic hips].

Y Hasegawa1.   

Abstract

We tried to determine the natural history of the hip and select the optimal treatment in 64 patients (94 hips with subluxation or dysplastic hips followed for more than ten years). Patients were classified into advanced and non-advanced groups according to radiographic analysis of the stage of the disease. Fourteen out of 43 hips (33%) developed early osteoarthritis (early OA) from pre-osteoarthritis (pre-OA) within an average of 9.4 years, while 34 out of 50 hips (68%) developed advanced-stage OA from early OA within an average of 7.7 years. In pre-OA, the CE angle, slope of the acetabular roof, acetabular head index, acetabular depth ratio and Japanese Orthopaedic Association (JOA) hip score were significant predictors, while in early OA, a broken Shenton's line, cranial joint space and JOA score were significant.

Entities:  

Mesh:

Year:  1994        PMID: 8047348

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  4 in total

1.  Periacetabular osteotomy: a review of swiss experience.

Authors:  Lorenz Büchler; Martin Beck
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

Review 2.  Influence of hip dysplasia on the development of osteoarthritis of the hip.

Authors:  A M Lievense; S M A Bierma-Zeinstra; A P Verhagen; J A N Verhaar; B W Koes
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

3.  [The natural history of developmental dysplasia of the hip. A meta-analysis of the published literature].

Authors:  J Ziegler; F Thielemann; C Mayer-Athenstaedt; K-P Günther
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

4.  Is Obesity Associated with Higher Complication Rates in Total Hip Arthroplasty for High-Riding Dysplastic Hips?

Authors:  Necdet Saglam; Deniz Gulabi; Anil Agar; Ahmet Can Erdem; Levent Bayam; Mehmet Erdem
Journal:  Indian J Orthop       Date:  2021-01-13       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.